🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a double blind, multicentre, randomized, placebo-controlled study. ...
Status
Completed
Location
Research Site
Start Date
2008-09
Trial ID
NCT00770588
The investigators performed a randomized, double blind controlled, prospect...
Status
Completed
Location
Multiple Locations
Start Date
2013-03
Trial ID
NCT02889692
Treatments Being Tested
A randomized, double-blind, positive controlled phase III study to evaluate...
Status
Active Not Recruiting
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2021-04-30
Trial ID
NCT03866499
Treatments Being Tested
RATIONALE: Gefitinib may stop the growth of tumor cells by blocking the enz...
Status
Completed
Location
Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center
Start Date
2004-01
Trial ID
NCT00080743
Treatments Being Tested
Drugs used in chemotherapy, such as docetaxel, work in different ways to st...
Status
Terminated
Location
Eastern Cooperative Oncology Group
Start Date
2004-08
Trial ID
NCT00088907
Intercalated administration of Iressa® (gefitinib) on days 5-18 of chemothe...
Status
Unknown
Location
National Cancer Center
Start Date
2012-03
Trial ID
NCT01502202
Treatments Being Tested
The primary purpose of this study is to assess the effectiveness of ZD1839 ...
Status
Completed
Location
Research Site
Start Date
2004-11
Trial ID
NCT00229723
Treatments Being Tested
The investigators performed a randomized, double-blind controlled, prospect...
Status
Unknown
Location
Multiple Locations
Start Date
2011-11
Trial ID
NCT01745302
This study is being carried out to see if treatment with ZD1839 (Gefitinib)...
Status
Completed
Location
Research Site
Start Date
2004-01
Trial ID
NCT00077025
Treatments Being Tested